[S5] Symposium 5"Genetic Diseases”

[S5-5] Hematopoietic stem cell-targeted gene therapy with lentiviral vectors to treat sickle cell disease

^○Naoya Uchida (National Institutes of Health)

Keywords:Hematopoietic stem cell transplantation, Gene therapy, Genome editing, Lentiviral vector

2022-Present       Leader, Gene Therapy Group in Cellular and Molecular Therapeutics Branch, NHLBI, NIH, Bethesda, MD, USA
2022-2023          Project Researcher in Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Japan
2020-2022          Associate Professor in Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Japan
2009-2022          Staff Scientist in Cellular and Molecular Therapeutics Branch, NHLBI, NIH, Bethesda, MD, USA
2007-2009          Postdoctoral Fellow in Molecular and Clinical Hematology Branch, NHLBI, NIH, Bethesda, MD, USA